Passion and purpose to transform standards of care

Jerry B. Gin, Ph.D., MBA, joined our Board of Directors in March 2016 and is Chair of our Compensation Committee and a member of our Audit Committee. Dr. Gin is currently the co-founder and Chief Executive Officer of Nuvora, Inc., a private drug delivery company with a technology platform focused on the sustained release of ingredients through the mouth for such indications as dry mouth, biofilm reduction, and sore throat/cough relief. Dr. Gin is also co-founder and Chairman of Livionex, a private platform technology company focused on oral care, ophthalmology, and wound care. Previously, Dr. Gin was co-founder, President, and Chief Executive Officer of Oculex Pharmaceuticals, which developed technology for controlled release delivery of drugs to the interior of the eye, specifically to treat macular edema, until it was acquired by Allergan. Prior to forming Oculex, Dr. Gin co-founded and took public ChemTrak, which developed a home cholesterol test commonly available in drug stores today. Prior to ChemTrak, Dr. Gin was Director of New Business Development and Strategic Planning for Syva, the diagnostic arm of Syntex Pharmaceuticals, Director for Pharmaceutical and Diagnostic businesses for Dow Chemical, and Director of BioScience Labs (now Quest Laboratories), the clinical laboratories of Dow Chemical. Dr. Gin received a B.S. degree in Chemistry from the University of Arizona, a Ph.D. in Biochemistry from the University of California, Berkeley, an MBA from Loyola College, and conducted post-doctoral research at the National Institutes of Health.